Cetera Investment Advisers
BNGO icon

Cetera Investment Advisers’s Bionano Genomics BNGO Stock Holding History

Cetera Investment Advisers’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,610
Closed -$106K – 3745
2024
Q2 		$106K Buy
2,610
+149
+6% +$8.19K ﹤0.01% 3504
2024
Q1 		$164K Buy
+2,461
New +$184K ﹤0.01% 3403
2023
Q3 		– Sell
-22
Closed -$7.96K – 2216
2023
Q2 		$7.96K Sell
22
-1
-4% -$451 ﹤0.01% 2165
2023
Q1 		$15.2K Hold
23
– – ﹤0.01% 2129
2022
Q4 		$20K Hold
23
– – ﹤0.01% 2062
2022
Q3 		$25K Sell
23
-2
-8% -$2.64K ﹤0.01% 1634
2022
Q2 		$21K Hold
25
– – ﹤0.01% 1792
2022
Q1 		$39K Sell
25
-10
-29% -$13.5K ﹤0.01% 1842
2021
Q4 		$63K Buy
35
+8
+30% +$21.4K ﹤0.01% 1821
2021
Q3 		$90K Sell
27
-8
-23% -$28K ﹤0.01% 1742
2021
Q2 		$152K Buy
35
+12
+52% +$47.4K ﹤0.01% 1698
2021
Q1 		$113K Buy
+23
New +$130K ﹤0.01% 1544

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

Cetera Investment Advisers's BNGO Position: Q3 2024 in Review

Cetera Investment Advisers sold out of Bionano Genomics (BNGO) in Q3 2024, closing a stake of 2,610 shares — an estimated $106K sold.

Cetera Investment Advisers first reported a position in BNGO in Q1 2021 and held it in 12 quarters. The position peaked at $164K in Q1 2024. 48 funds tracked by Wall St. Rank hold BNGO as of Q3 2024.

  • Cetera Investment Advisers reported no remaining Bionano Genomics position as of Q3 2024 after selling out during the quarter.
  • Cetera Investment Advisers sold 2,610 Bionano Genomics shares in Q3 2024, an estimated $106K.
  • Cetera Investment Advisers first reported a position in Bionano Genomics in Q1 2021 and held it in 12 quarters.
  • Cetera Investment Advisers's Bionano Genomics position peaked at $164K in Q1 2024.
  • 48 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2024.

Based on Cetera Investment Advisers's 13F filing for Q3 2024, filed 13 Nov 2024.